ERIS LIFESCIENCES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 914 INR | +1.84% |
|
+0.64% | +0.37% |
| 05-22 | Eris Lifesciences Posts Gains in Fiscal Q4 Consolidated Net Profit | MT |
| 05-21 | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 727B | ||||||
| 347B | ||||||
| 319B | ||||||
| 274B | ||||||
| 238B |
